Short Summary
This procedural order concerns a patent infringement dispute involving standard-essential patents (SEPs) for 3G and 4G standards. The plaintiff (Panasonic) alleges infringement of its patent, while the defendants (including OPPO) counter that Panasonic's licensing demands during prior negotiations were not FRAND. Both parties requested the court to order production of evidence, including license agreements, to determine what constitutes FRAND terms in this case.
Detailed Summary
This case involves a patent infringement action filed by Panasonic against multiple defendants, including OPPO (referred to as Beklagte zu 1). The dispute centers on standard-essential patents (SEPs) for 3G and 4G mobile telecommunications standards. Prior to the litigation, the parties had engaged in unsuccessful license negotiations concerning Panasonic's 3G and 4G patent portfolio. The defendants raised the defense that Panasonic's licensing demands during these negotiations were not FRAND (Fair, Reasonable, and Non-Discriminatory), and according to the defendants, the question of what constitutes FRAND terms is at the center of the dispute. Both parties maintained that they had acted in a FRAND-compliant manner during the licensing negotiations.
Both the plaintiff and defendants requested the court to order the production of evidence to support their respective positions on the FRAND question. The plaintiff sought to rely on license agreements it had itself concluded. Defendant 1 (OPPO) made extensive requests for the production of documents, seeking: (1) all license agreements concluded by Panasonic covering 3G and/or 4G SEPs relating to mobile devices; (2) all license agreements concluded by third parties covering 3G and/or 4G SEPs that were or are owned by Panasonic and under Panasonic's control; (3) specific license agreements Panasonic concluded with companies referred to as 'X' and 'Y' that Panasonic referenced during negotiations; (4) all license agreements Panasonic concluded with companies referred to as 'M.' and 'Q.' covering 3G and/or 4G SEPs; (5) a complete overview of all transactions in which Panasonic transferred 3G and/or 4G SEPs; (6) all agreements related to such transactions, including supplementary agreements and financial arrangements providing Panasonic with monetary benefits; and (7) a forward-looking obligation requiring Panasonic to disclose any new license agreements concluded during the proceedings within 14 days of signing or after any contractual notice period. OPPO also requested permission to submit its own license agreements with third parties covering 3G and/or 4G SEPs, and sought an order that the evidence need not be translated.
& Analysis: The provided text is a procedural order (Verfahrensanordnung) issued by the Local Chamber Munich on April 3, 2024, addressing the parties' respective applications for the production of evidence. The full reasoning of the court is not contained in the excerpt provided, as the text appears to be truncated.
Final Order & Ruling: The document is a procedural order concerning the management of evidence in the case, with the court addressing the various requests for production of documents submitted by both the plaintiff and the defendants. The complete ruling and its operative provisions are not fully set out in the provided text excerpt.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Munich (DE) Local Division. Understanding the court's reasoning in Panasonic Holdings Corporation , Panasonic Holdings Corporation vs OROPE Germany GmbH, Guangdong OPPO Mobile Telecommunications Corp. Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Fujifilm CorporationvsKodak Graphic Communications GmbH , Kodak Holding GmbH, Kodak GmbH
Fujifilm Corporation sued three German Kodak entities for alleged infringement of European Patent EP 3 511 174 B1, which relates to lithographic printing plate precursors. The defendants counterclaimed for revocation, challenging novelty, inventive step, and alleging added matter. The Mannheim Local Division found infringement by the defendants' SONORA XTRA-3 product, dismissed the counterclaim for revocation, and granted injunctive relief, information orders, destruction and recall orders, and an interim costs award of EUR 300,000.
10x Genomics, Inc.vsCurio Bioscience Inc.
The Düsseldorf Local Division ordered the release of a €200,000 security for costs deposited by Curio Bioscience Inc. in proceedings concerning EP 2 697 391 B1. Following the Court's cost decisions and the Claimant's receipt of the amounts owed, the Defendant applied for release of the security, to which the Claimant did not object.
A. Menarini Diagnostics s.r.lvsInsulet Corporation
1 Milan - Local Division UPC_CFI_400/2024 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 04/09/2024 Order no. ORD_45723/2024 APPLICANT 1) A. Menarini Diagnostics s.r.l. (Applicant) - Via Dei Sette Santi 3 - 50131 - Florence – IT Represented
Koninklijke Philips N.V.vsBelkin GmbH, Belkin Limited, Belkin International, Inc.,
Koninklijke Philips N.V. sued several Belkin entities and their directors for infringement of European Patent EP 2 867 997 B1, which relates to wireless inductive power transfer. The dispute concerned the interpretation of claim 20 of the patent and whether the Belkin defendants' activities constituted patent infringement. The Local Chamber Munich issued its main decision on 13 September 2024, addressing issues including claim construction, the definition of an infringer, and the possibility of injunctions against company officers as intermediaries.
Celltrion Healthcare Italy S.R.L., Celltrion Healthcare Belgium SPRL, Celltrion Healthcare Finland Oy, Celltrion Healthcare Netherlands B.V., Celltrion Healthcare France SAS, Celltrion Healthcare Deutschland GmbH, Celltrion Healthcare Hungary Kft.vsNovartis AG, Genentech, Inc.
1. Art. 25 UPCA constitutes uniform substantive law and Art. 62 (1) UPCA uniform procedural law, which takes precedence over national patent laws and whose content is to be inter- preted independently by the Court. 2. A situation of imminent infringement may be characterised by certain circumstances which suggest that the infringement has not yet occurred, but that the potential infringer has al- ready set the stage for it to occur. The infringement is only a matter of starting the action
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.